Marco V.
- Country
- Italy
- Department
- Dipartimento cardio-toraco-vascolare
Research Overview
Data & Insights
Has run more than one trial at 0 of 35 partner sites.
Specializations
Cardiovascular Research
The investigator specializes in the study of pulmonary arterial hypertension (PAH), conducting innovative research to advance treatment options for this cardiovascular condition.
- PAH Treatment Development
- Cardiovascular Drug Evaluation
- Systemic Drug Exposure Assessment
The investigator's work focuses on evaluating novel therapeutic approaches for PAH management, particularly examining treatment safety profiles and therapeutic effectiveness in cardiovascular medicine.
Clinical Pharmacology
The investigator's expertise extends to pharmacological research, with particular emphasis on understanding drug exposure and dosing optimization in cardiovascular treatments.
- Weight-Based Dosing Studies
- Drug Exposure Analysis
- Long-term Safety Assessment
Their research encompasses the evaluation of steady-state drug exposure and the development of precise dosing strategies for therapeutic interventions.
Therapeutic Safety
The investigator demonstrates dedicated focus on safety and tolerability assessment of cardiovascular treatments through extended observation periods.
- Long-term Treatment Monitoring
- Treatment Tolerability Studies
- Safety Profile Development
Their research methodology includes comprehensive evaluation of treatment safety parameters over extended therapeutic periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.